No Data
No Data
AstraZeneca (AZN) Receives a Hold From Jefferies
Express News | AstraZeneca : Jefferies Raises Target Price to $74 From $71
AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment
The European Medicines Agency (EMA) has accepted AstraZeneca Plc's (NASDAQ:AZN) marketing authorization application for sipavibart for pre-exposure prophylaxis (prevention) of COVID-19 in immunocompro
AstraZeneca Shares Update and Global Reach
Express News | AstraZeneca's Marketing Authorization Application For Sipavibart Has Been Accepted Under An Accelerated Assessment Procedure By The European Medicines Agency, For The Pre-exposure Prophylaxis (Prevention) Of Covid-19 In Immunocompromised Patients
AstraZeneca's Combination Formulation for Endometrial Cancer Gains Support for EU Application
AstraZeneca (AZN.L, AZN.ST) said Monday that the European Medicines Agency's Committee for Medicinal products for Human Use recommended for approval its combination formulation of Imfinzi and Lynparza